Genoway Stock

Genoway EBITDA per Employee

The EBITDA per Employee of Genoway (ALGEN.PA) as of Sep 6, 2026 is 5,923.52 EUR. In the previous year, EBITDA per Employee was 38,951.33 EUR — a change of -84.79% (lower).

EBITDA per Employee

5,923.52EUR

YoY

-84.79%

Last updated:

EBITDA per Employee of Genoway is 2026 5,923.52 EUR. EBITDA per Employee of Genoway was 2025 38,951.33 EUR. It decreases by -84.79% lower compared to the previous year.

The Genoway EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2018
12,626.55 EUR
Jan 1, 2019
3,992.72 EUR
Jan 1, 2020
-23,486.74 EUR
Jan 1, 2021
-23,633.17 EUR
Jan 1, 2022
30,685.27 EUR
Jan 1, 2023
55,886.69 EUR
Jan 1, 2024
38,951.33 EUR
Jan 1, 2025
5,923.52 EUR
The Genoway EBITDA per Employee history
YEAREBITDA per EmployeeYoY
5,923.52EUR-84.79%
38,951.33EUR-30.30%
55,886.69EUR+82.13%
30,685.27EUR-229.84%
-23,633.17EUR+0.62%
-23,486.74EUR-688.24%
3,992.72EUR-68.38%
12,626.55EUR+3.79%
12,165.27EUR-8.02%
13,226.61EUR+55.82%
8,488.63EUR-1.65%
8,630.99EUR—
Access this data via the Eulerpool API
Get Free API Key

Genoway Stock analysis

What does Genoway do? Genoway SA is a biotechnology company based in Lyon, France. It was founded in 2002 by Pierre Cadinot. The company specializes in the production of genetically modified mice for disease research and the development of new therapies. The business model of Genoway is to provide customers with customized genetically modified mice. The company offers a wide range of services, from consulting during the design phase to the delivery of modified mice. The company also offers services in the field of cell culture and transgene expression. Genoway is divided into different divisions to meet specific customer needs. For example, there is the "Knockout Mice" division, which specializes in producing mice that lack a specific target gene. These mice are used to study the function of the missing gene in vivo. Another area of Genoway is the production of "humanized mouse models". These are mice in which human genes have been inserted to model specific human diseases or to test the efficacy of drugs. These humanized mice are an important part of drug research in the pharmaceutical industry. Genoway also offers services in the field of inducible expression. This involves triggering the expression of a target gene in vivo to study the effects of the protein. This technology is particularly useful in the research of diseases such as cancer, where certain genes are only active in specific cells. In addition to these specialized services, Genoway also offers a wide range of standard services, such as the creation of stable cell lines or transgene expression in various organs and tissues. Genoway is a leading company in the development of genetically modified models for the study of human diseases. The company works closely with its customers to develop customized solutions that meet the specific requirements of each project. With its divisions and services, it aims to support its customers in the development of new therapies and drugs. Genoway is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genoway stock

EBITDA per Employee of Genoway is 5,923.52 EUR in 2026.

EBITDA per Employee of Genoway changed from 38,951.33 EUR to 5,923.52 EUR, representing a -84.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Genoway since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Genoway historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Workforce — Genoway

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Genoway